Associations of Left Atrial Volume Index to Left Ventricular Ejection Fraction Ratio with Clinical Outcomes in Transthyretin Cardiac Amyloidosis

Associations of Left Atrial Volume Index to Left Ventricular Ejection Fraction Ratio with Clinical Outcomes in Transthyretin Cardiac Amyloidosis

Background: Transthyretin amyloid cardiomyopathy (ATTR-CM) affects all cardiac chambers to cause left ventricular (LV) deformation as well as left atrial (LA) remodeling and functional impairment. We investigated the associations of the LA volume index (LAVI):LV ejection fraction (LVEF) ratio with t...

Descripció completa

Dades bibliogràfiques
Autors principals:	Yeabsra K. Aleligne, Machelle D. Wilson, Martin Cadeiras, Michael Gibson, Shirin Jimenez, Stella Yala, Pablo E. Acevedo, David A. Liem, Julie T. Bidwell, Imo A. Ebong
Format:	Article
Idioma:	English
Publicat:	MDPI AG 2024-11-01
Col·lecció:	Journal of Cardiovascular Development and Disease
Matèries:	cardiac amyloidosis transthyretin clinical outcomes echocardiography
Accés en línia:	https://www.mdpi.com/2308-3425/11/11/363

Ítems similars

Left ventricular deformation and torsion assessed by speckle-tracking echocardiography in patients with mutated transthyretin-associated cardiac amyloidosis and the effect of diflunisal on myocardial function
per: Jun Koyama, et al.
Publicat: (2015-12-01)

Clinical case of hereditary transthyretin amyloidosis
per: N. Spasova, et al.
Publicat: (2024-12-01)

Diagnostic algorithm in transthyretin amyloidosis with cardiomyopathy
per: Mariana Gospodinova, et al.
Publicat: (2020-07-01)

Outcomes in Cardiac Transthyretin Amyloidosis and Association With New York Heart Association Class: Real‐World Data
per: Maximilian Leo Müller, et al.
Publicat: (2024-07-01)

Specific Therapy for Transthyretin Cardiac Amyloidosis: A Systematic Literature Review and Evidence‐Based Recommendations
per: Nuno Marques, et al.
Publicat: (2020-10-01)

Trajectory of left ventricular geometry and diastolic dysfunction in hereditary transthyretin cardiac amyloidosis
per: Tatsuya Akatsuka, et al.
Publicat: (2021-08-01)

Transthyretin Amyloidosis Therapies: Guiding the Future
per: Alejandra González-Duarte
Publicat: (2021-01-01)

Hereditary Transthyretin Amyloidosis: How to Differentiate Carriers and Patients Using Speckle-Tracking Echocardiography
per: Daniela Di Lisi, et al.
Publicat: (2023-12-01)

New simple and quick method to analyze serum variant transthyretins: direct MALDI method for the screening of hereditary transthyretin amyloidosis
per: Toshiya Nomura, et al.
Publicat: (2019-05-01)

A Clinical Case of the Hereditary Transthyretin Amyloidosis
per: E. V. Reznik, et al.
Publicat: (2021-05-01)

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
per: Faruk Uğur Doğan, et al.
Publicat: (2019-03-01)

Clinical and genetic profiles of patients with hereditary and wild-type transthyretin amyloidosis: the Transthyretin Cardiac Amyloidosis Registry in the state of São Paulo, Brazil (REACT-SP)
per: Fábio Fernandes, et al.
Publicat: (2024-07-01)

Identification of wild‐type transthyretin cardiac amyloidosis in patients with carpal tunnel syndrome surgery (CACTuS)
per: Bertil Ladefoged, et al.
Publicat: (2023-02-01)

Hereditary systemic transthyretin amyloidosis: a clinical case and an opinion on the problem
per: A. S. Draganova, et al.
Publicat: (2019-07-01)

Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis
per: Hiroki Yamaguchi, et al.
Publicat: (2022-03-01)

Epidemiology of variant transthyretin amyloidosis at a reference center in Argentina
per: Maria S. Saez, et al.
Publicat: (2021-11-01)

Disease-Modifying Therapy for Transthyretin Amyloidosis
per: Nowell M. Fine, MD, SM
Publicat: (2020-11-01)

Phenotypic heterogeneity and diagnostic features of transthyretin amyloidosis with polyneuropathy
per: S. S. Nikitin, et al.
Publicat: (2021-12-01)

Hereditary transthyretin amyloidosis
per: T. A. Adyan, et al.
Publicat: (2020-01-01)

Diagnosis and Screening of Patients with Hereditary Transthyretin Amyloidosis (hATTR): Current Strategies and Guidelines
per: Benson MD, et al.
Publicat: (2020-08-01)

Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report
per: Hiroyuki Yamamoto, et al.
Publicat: (2018-12-01)

Prevalence of transthyretin amyloidosis among heart failure patients with preserved ejection fraction in Japan
per: Takanori Naito, et al.
Publicat: (2023-06-01)

Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population
per: Andreea Jercan, et al.
Publicat: (2020-01-01)

Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis
per: Hiroaki Matsushita, et al.
Publicat: (2022-06-01)

Lack of Association Between Neurohormonal Blockade and Survival in Transthyretin Cardiac Amyloidosis
per: Richard K. Cheng, et al.
Publicat: (2021-12-01)

Modulation of the Mechanisms Driving Transthyretin Amyloidosis
per: Filipa Bezerra, et al.
Publicat: (2020-12-01)

A Comparative Study of the Electroneurographic Findings in Amyloidotic Polyneuropathy in Patients with Light-Chain Amyloidosis and Glu54Gln Transthyretin Amyloidosis
per: Mirela Drăghici, et al.
Publicat: (2024-12-01)

Oxidative Stress in Transthyretin-Mediated Amyloidosis: An Exploratory Study
per: Marco Fiore, et al.
Publicat: (2024-08-01)

Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey
per: Juan González-Moreno, et al.
Publicat: (2023-12-01)

The Transthyretin/Oleuropein Aglycone Complex: A New Tool against TTR Amyloidosis
per: Francesco Bemporad, et al.
Publicat: (2022-02-01)

Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications
per: Giedre Balciunaite, et al.
Publicat: (2020-03-01)

A clinical case of transthyretin amyloidosis with manifestations of seronegative arthritis
per: V. A. Mareeva, et al.
Publicat: (2024-02-01)

Coexistence of Light Chain and Transthyretin Cardiac Amyloidosis
per: Abhishek Gami, MD, et al.
Publicat: (2024-04-01)

Hereditary transthyretin amyloidosis: a case report
per: Angela Lee, et al.
Publicat: (2022-06-01)

Targeted sequencing of selected functional genes in patients with wild-type transthyretin amyloidosis
per: Inmaculada Moreno-Gázquez, et al.
Publicat: (2023-10-01)

Hereditary and wild type transthyretin amyloid cardiomyopathy in Bulgaria in patients suspected for cardiac amyloidosis
per: S. Stefanov, et al.
Publicat: (2024-09-01)

What's new in the treatment of amyloidosis? Part 2: Cardiomyopathy due to transthyretin amyloidosis
per: Gisela Bendelman, et al.
Publicat: (2024-03-01)

Specific therapeutic options for transthyretin amyloidosis
per: Zoltán Pozsonyi
Publicat: (2024-12-01)

Vitreous amyloidosis with autonomic neuropathy of the digestive tract associated with a novel transthyretin p.Gly87Arg variant in a Bangladeshi patient: a case report
per: Benjamin Terrier, et al.
Publicat: (2017-08-01)

Hereditary Transthyretin Amyloidosis in Patients Referred to a Genetic Testing Program
per: Kunal Bhatt, et al.
Publicat: (2024-12-01)